Protara Therapeutics (TARA) Short Interest Ratio & Short Volume

Protara Therapeutics logo
$2.32 -0.07 (-2.73%)
As of 11:23 AM Eastern
This is a fair market value price provided by Massive. Learn more.

Protara Therapeutics Short Interest Overview

As of October 30, 2026, Protara Therapeutics (TARA) had a short interest of 3.24 million shares sold short, representing 5.93% of the public float. This marks a 46.89% decrease in short interest since the prior report. The short interest ratio (days to cover) is 2.9, meaning it would take 2.9 days of the average trading volume of 881,761 shares to cover all short positions.

Current Short Interest
3,236,659 shares
Previous Short Interest
6,094,189 shares
Change Vs. Previous Report
-46.89%
Dollar Volume Sold Short
$8.03 million
Short Interest Ratio
2.9 Days to Cover
Last Record Date
October 30, 2026
Outstanding Shares
61,570,000 shares
Short Percent of Float
5.93%
Today's Trading Volume
143,372 shares
Average Trading Volume
881,761 shares
Today's Volume Vs. Average
16%
Short Selling Protara Therapeutics?
A Guide To High-Short-Interest Stocks

Sign up to receive the latest short interest report for Protara Therapeutics and its competitors with MarketBeat's FREE newsletter.

Get Report
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Charts & View Short Interest History

TARA Short Interest Over Time

TARA Days to Cover Over Time

TARA Percentage of Float Shorted Over Time

Protara Therapeutics Tesla Short Interest History & Recent Changes

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
10/30/20263,236,659 shares $8.03 million -46.9%5.9%2.87 $2.48
10/15/20266,094,189 shares $14.63 million +5.2%11.2%4.32 $2.40
9/30/20265,791,421 shares $17.66 million +31.1%10.6%2.91 $3.05
9/15/20264,417,095 shares $16.56 million -0.3%8.1%10.34 $3.75
8/31/20264,431,963 shares $17.11 million -2.4%8.1%12.36 $3.86
8/14/20264,541,333 shares $18.03 million +1.0%8.3%12.03 $3.97
7/31/20264,495,001 shares $17.62 million -1.0%8.7%11.47 $3.92
7/15/20264,541,891 shares $18.71 million +4.8%8.7%6.72 $4.12
6/30/20264,335,683 shares $16.56 million -2.9%8.3%5.12 $3.82
6/15/20264,465,466 shares $17.59 million -24.2%8.6%6.55 $3.94
5/29/20265,888,171 shares $27.38 million +57.5%11.3%6.17 $4.65
5/15/20263,739,353 shares $19.07 million -37.6%7.2%5.61 $5.10
4/30/20265,995,936 shares $31.96 million +4.4%11.8%9.57 $5.33
4/15/20265,745,340 shares $29.93 million +3.5%11.1%11.15 $5.21
3/31/20265,550,159 shares $28.92 million -13.3%10.7%6.14 $5.21
3/13/20266,399,060 shares $33.66 million +30.7%13.5%6.19 $5.26
2/27/20264,895,488 shares $31.14 million +48.0%10.8%3.08 $6.36
2/13/20263,308,046 shares $21.54 million +16.8%6.4%6.15 $6.51
1/30/20262,832,933 shares $20.06 million +12.3%6.3%2.34 $7.08
1/15/20262,521,732 shares $12.71 million +14.7%5.6%2.06 $5.04
12/31/20252,198,324 shares $11.72 million -15.5%4.9%3.95 $5.33
12/15/20252,602,314 shares $14.31 million -10.5%5.8%1.68 $5.50
11/28/20252,908,827 shares $21.45 million +4.8%8.6%3.12 $7.37
11/14/20252,774,733 shares $15.29 million -1.8%7.9%6.51 $5.51
10/31/20252,825,459 shares $14.64 million -1.0%8.0%8.27 $5.18
10/15/20252,860,000 shares $16.36 million +16.3%8.5%7 $5.72
9/30/20252,460,000 shares $10.70 million -8.6%N/A6.7 $4.35
9/15/20252,690,000 shares $8.50 million -10.0%N/A7.5 $3.16
8/31/20252,990,000 shares $9.33 million +7.9%8.5%10.8 $3.12
8/15/20252,770,000 shares $8.39 million -5.5%N/A9.3 $3.03
7/31/20252,930,000 shares $9.08 million +1.4%8.3%9.1 $3.10
7/15/20252,890,000 shares $8.81 million +2.1%N/A7.1 $3.05
6/30/20252,830,000 shares $8.57 million +28.6%8.0%6.5 $3.03
6/15/20252,200,000 shares $6.91 million +0.9%6.2%6.3 $3.14
5/31/20252,180,000 shares $6.71 million -3.1%12.1%6.2 $3.08
5/15/20252,250,000 shares $7.00 million -9.3%12.5%6.2 $3.11
4/30/20252,480,000 shares $8.68 million +22.2%N/A7 $3.50
4/15/20252,030,000 shares $8.47 million -2.4%11.2%6.8 $4.17
3/31/20252,080,000 shares $8.86 million +16.9%11.5%7.3 $4.26
3/15/20251,780,000 shares $7.67 million -40.1%9.9%5.1 $4.31
Your Copy is on Hold (Claim it now) (Ad)

James Altucher, who called NVIDIA in 2008 and SpaceX years before a single share traded, has a new report on Elon Musk's next big industry play. He estimates it could create 1.8 million new millionaires in the coming years, and shows how to position in the company at its center for under $60. Inside: the company's name and ticker, plus an FCC filing James believes reveals Elon's plan to take over a $25 trillion industry. He also flags December 8 as a key date.tc pixel

Claim your copy of James Altucher's new Elon Musk report today.
2/28/20252,970,000 shares $11.11 million -28.4%16.5%1.3 $3.74
2/15/20254,150,000 shares $17.26 million -1.2%23.0%1.8 $4.16
1/31/20254,200,000 shares $20.66 million -4.6%N/A1.8 $4.92
1/15/20254,400,000 shares $20.55 million -13.7%N/A1.9 $4.67
12/31/20245,100,000 shares $26.93 million -5.7%N/A2.3 $5.28
12/15/20245,410,000 shares $32.35 million +79.1%N/A2.5 $5.98
11/30/20243,020,000 shares $9.09 million +10.6%N/A1.5 $3.01
11/15/20242,730,000 shares $6.74 million -0.4%N/A16.2 $2.47
10/31/20242,740,000 shares $6.88 million +18.1%N/A15.3 $2.51
10/15/20242,320,000 shares $4.15 million +7.9%N/A14.2 $1.79
9/30/20242,150,000 shares $3.93 million +2.4%N/A13.7 $1.83
9/15/20242,100,000 shares $3.95 million +2.4%N/A12.9 $1.88
8/31/20242,050,000 shares $4.10 million +9.0%N/A12.3 $2.00
8/15/20241,880,000 shares $3.85 million +8.1%N/A10.7 $2.05
7/31/20241,740,000 shares $3.88 million -3.3%N/A6.9 $2.23
7/15/20241,800,000 shares $4.28 million +1.7%N/A6.3 $2.38
6/30/20241,770,000 shares $3.68 million +2.9%N/A5.9 $2.08
6/15/20241,720,000 shares $4.42 million +8.9%N/A4.2 $2.57
5/31/20241,580,000 shares $4.44 million +16.2%N/A4 $2.81
5/15/20241,360,000 shares $5.05 million +32.0%N/A3.6 $3.71
4/30/20241,030,000 shares $3.07 million +158.6%N/A3.5 $2.98
4/15/2024398,300 shares $1.13 million +510.9%4.4%1.6 $2.84
3/31/202465,200 shares $261.45 thousand +6.2%0.7%0.3 $4.01
3/15/202461,400 shares $225.95 thousand -22.3%0.7%0.8 $3.68
2/29/202479,000 shares $360.24 thousand +33.9%0.9%1.1 $4.56
2/15/202459,000 shares $208.27 thousand -33.0%0.7%0.8 $3.53
1/31/202488,100 shares $224.66 thousand +19.2%1.1%1.5 $2.55
1/15/202473,900 shares $170.71 thousand +1.5%0.9%1.3 $2.31
12/31/202372,800 shares $136.51 thousand +46.8%0.9%1.3 $1.88
12/15/202349,600 shares $88.29 thousand -16.2%0.6%1.1 $1.78
11/30/202359,200 shares $85.84 thousand +22.3%0.7%1.6 $1.45
11/15/202348,400 shares $58.08 thousand +1.7%0.6%1.6 $1.20
10/31/202347,600 shares $59.27 thousand -3.3%0.6%1.9 $1.25
10/15/202349,200 shares $81.18 thousand -4.3%0.6%2.5 $1.65
9/30/202351,400 shares $85.84 thousand +5.5%0.6%2.2 $1.67
9/15/202348,700 shares $90.10 thousand -7.4%0.6%1.8 $1.85
8/31/202352,600 shares $114.67 thousand +14.4%0.6%1.8 $2.18
8/15/202346,000 shares $109.02 thousand -40.8%0.6%1.4 $2.37
7/31/202377,700 shares $201.24 thousand -28.5%0.9%2.3 $2.59
7/15/2023108,600 shares $298.65 thousand +10.0%1.3%2.9 $2.75
6/30/202398,700 shares $235.89 thousand -9.0%1.2%2.7 $2.39
6/15/2023108,400 shares $308.94 thousand +11.0%1.3%3.2 $2.85
5/31/202397,700 shares $272.58 thousand +0.2%1.2%2.7 $2.79
5/15/202397,500 shares $328.58 thousand -4.6%1.2%2.6 $3.37
4/30/2023102,200 shares $322.95 thousand +34.1%1.2%3.2 $3.16
4/15/202376,200 shares $221.74 thousand -0.4%0.9%2.4 $2.91
3/31/202376,500 shares $239.45 thousand -0.4%0.9%3.2 $3.13
3/15/202376,800 shares $235.78 thousand -0.9%0.9%3.2 $3.07
2/28/202377,500 shares $273.58 thousand -5.8%0.9%4.2 $3.53
2/15/202382,300 shares $264.18 thousand -2.4%0.9%4.5 $3.21
My $247 scanner for $7 (Ad)

Bill Poulos is cutting the price of his $247 Instant Scanner to $7 for Black Friday. It's a one-time payment that covers a full year, with no subscription and no re-bills. Every night after the close, the scanner screens nearly a thousand of America's biggest stocks. It returns a short list of qualifying setups with the exact buy price next to each one. There's nothing to install. If you decide it's not for you, you get the $7 back and keep the scanner for the year.tc pixel

Get the Instant Scanner for $7 in the Black Friday sale today.
1/31/202384,300 shares $275.24 thousand -0.6%1.0%3.5 $3.27
1/15/202384,800 shares $284.93 thousand -1.5%1.0%3.2 $3.36
12/30/202286,100 shares $230.75 thousand +8.4%1.0%3 $2.68
12/15/202279,400 shares $243.76 thousand -30.8%0.9%2.5 $3.07
11/30/2022114,700 shares $404.89 thousand +22.7%1.3%3 $3.53
11/15/202293,500 shares $276.76 thousand +7.5%1.0%2.2 $2.96
10/31/202287,000 shares $267.09 thousand +2.7%1.0%2 $3.07
10/15/202284,700 shares $281.20 thousand -16.6%1.0%2.1 $3.32
9/30/2022101,600 shares $300.74 thousand -9.5%1.2%2.8 $2.96
9/15/2022112,200 shares $433.09 thousand +14.5%1.3%2.6 $3.86
8/31/202298,000 shares $338.10 thousand +9.0%1.2%2.3 $3.45
8/15/202289,900 shares $311.95 thousand -1.0%1.1%2.4 $3.47
7/31/202290,800 shares $271.49 thousand -32.7%1.1%2.4 $2.99
7/15/2022135,000 shares $422.55 thousand +32.1%1.6%3.6 $3.13
6/30/2022102,200 shares $299.45 thousand -32.4%1.2%2.7 $2.93
6/15/2022151,200 shares $471.74 thousand -5.0%1.8%4.7 $3.12
5/31/2022159,200 shares $531.73 thousand +5.5%1.9%5.6 $3.34
5/15/2022150,900 shares $436.10 thousand +1.6%1.8%4.9 $2.89
4/30/2022148,500 shares $543.51 thousand -6.8%1.8%4.9 $3.66
4/15/2022159,400 shares $730.05 thousand -15.5%1.9%4.8 $4.58
3/31/2022188,700 shares $964.26 thousand -8.0%2.2%5 $5.11
3/15/2022205,100 shares $916.80 thousand -30.4%2.4%3.9 $4.47
2/28/2022294,500 shares $1.36 million +17.9%3.5%5.1 $4.63
2/15/2022249,900 shares $1.31 million -10.3%3.0%4 $5.25
1/31/2022278,500 shares $1.45 million -8.3%3.2%3.7 $5.21
1/15/2022303,700 shares $1.93 million -19.8%3.4%3.5 $6.37
12/31/2021378,600 shares $2.56 million -3.1%4.2%1.2 $6.75
12/15/2021390,700 shares $2.56 million +32.3%4.3%1.3 $6.56
11/30/2021295,300 shares $2.03 million -7.4%3.2%0.9 $6.89

TARA Short Interest - Frequently Asked Questions

Short interest is the volume of Protara Therapeutics shares that have been sold short but have not yet been closed out or covered. As of October 30th, investors have sold 3,236,659 shares of TARA short. 5.93% of Protara Therapeutics' shares are currently sold short. Learn More on Protara Therapeutics' current short interest.

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. TARA shares currently have a short interest ratio of 2.9. Learn More on Protara Therapeutics's short interest ratio.

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 5.93% of Protara Therapeutics' floating shares are currently sold short.

Protara Therapeutics saw a decrease in short interest since the prior report. As of October 30th, there was short interest totaling 3,236,659 shares, a decrease of 46.9% from the previous total of 6,094,189 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

5.93% of Protara Therapeutics' shares are currently sold short. Here is how the short interest of companies in the industry of "biotechnology" compare to Protara Therapeutics: Neurogene Inc. (32.17%), Puma Biotechnology, Inc. (10.70%), Entera Bio Ltd. (4.22%), Climb Bio, Inc. (18.88%), Valneva SE Sponsored ADR (0.06%), Capricor Therapeutics, Inc. (35.55%), Shattuck Labs, Inc. (11.74%), Sensei Biotherapeutics, Inc. (11.36%), Aclaris Therapeutics, Inc. (8.69%), Crescent Biopharma, Inc. (14.90%),

As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($77.66 billion), Invesco QQQ ($57.17 billion), iShares Russell 2000 ETF ($21.91 billion), SPDR S&P Biotech ETF ($10.53 billion), Union Pacific Corporation ($9.26 billion), iShares iBoxx $ High Yield Corporate Bond ETF ($9.05 billion), Nebius Group N.V. ($7.85 billion), iShares 20+ Year Treasury Bond ETF ($7.81 billion), Moderna, Inc. ($7.36 billion), and iShares iBoxx $ Investment Grade Corporate Bond ETF ($7.20 billion). View all of the most shorted stocks.

Short selling TARA is an investing strategy that aims to generate trading profit from Protara Therapeutics as its price is falling. TARA shares are trading down $0.15 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for Protara Therapeutics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of TARA, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including TARA, twice per month. The most recent reporting period available is October, 30 2026.

Understanding short interest metrics can help you assess how traders are positioning around a stock like TARA:

  • Shares Sold Short: The total number of shares that have been sold by short sellers but have not yet been covered or closed out. A high number may indicate bearish sentiment.
  • Short Float: The percentage of a company’s publicly available shares (or "float") that are sold short. A higher short float suggests a greater portion of the stock is being bet against.
  • Days to Cover (Short Interest Ratio): This estimates how many days it would take short sellers to cover their positions, based on average daily trading volume. Higher values can signal potential for a short squeeze if buying pressure increases.

These metrics are often used by traders to gauge sentiment, volatility risk, and the potential for price movements based on short covering activity.



Short interest data for NASDAQ:TARA is sourced from the Financial Industry Regulatory Authority (FINRA), with the most recent report published on 11/10/2026. FINRA publishes updated short interest twice a month.
From Our Partners